Orchard Therapeutics
ORTX
#7081
Rank
HK$2.95 B
Marketcap
HK$129.93
Share price
0.00%
Change (1 day)
243.08%
Change (1 year)

Revenue for Orchard Therapeutics (ORTX)

Revenue in 2023 (TTM): HK$0.17 Billion

According to Orchard Therapeutics 's latest financial reports the company's current revenue (TTM ) is HK$0.16 Billion. In 2022 the company made a revenue of HK$0.17 Billion an increase over the revenue in the year 2021 that were of HK$13.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Orchard Therapeutics from 2019 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) HK$0.17 B-3.41%
2022 HK$0.17 B1255.26%
2021 HK$13.06 M-35.07%
2020 HK$20.11 M2.79%
2019 HK$19.57 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$4.49 B 2,545.44% Jersey
HK$6.10 B 3,493.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.56 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.16 B 0.00%๐Ÿ‡ฌ๐Ÿ‡ง UK